跳至主要内容
临床试验/IRCT20210125050137N1
IRCT20210125050137N1招募中2 期

The efficacy comparison of single-dose vs. multi-dose of Ketamine on treatment-resistant depression's symptoms; a non-inferiority RCT study

Kashan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Males and females, aged 18 -65 years old
  • DSM-V Major Depression Disorder diagnosis confirmed by The Hamilton Depression Rating Scale
  • The patient has refractory depression, a type of major depression that has not responded to traditional treatment options and the first line of treatment and has taken at least 2 trials of antidepressant drug without sufficient response

排除标准

  • Having other psychiatric illnesses other than major depression
  • Having a history of one or more seizures for no apparent reason
  • Pregnancy and lactation
  • Bipolar disorder
  • Having uncontrolled non-psychiatric illnesses, including cardiovascular disease
  • Having a history of stimulant use during the last three months

研究者

相似试验